361 Capital’s Cigna CI Stock Holding History

361 Capital’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,085	Closed	-$2.26M	–	246
2017 Q3	$2.26M	Sell	12,085 -12,471	-51%	-$2.22M	0.43%	93
2017 Q2	$4.11M	Buy	+24,556	New	+$3.95M	0.69%	58

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

361 Capital's CI Position: Q4 2017 in Review

361 Capital sold out of Cigna (CI) in Q4 2017, closing a stake of 12,085 shares — an estimated $2.26M sold.

361 Capital first reported a position in CI in Q2 2017 and held it in 2 quarters. The position peaked at $4.11M in Q2 2017. 865 funds tracked by Wall St. Rank hold CI as of Q4 2017.

361 Capital reported no remaining Cigna position as of Q4 2017 after selling out during the quarter.
361 Capital sold 12,085 Cigna shares in Q4 2017, an estimated $2.26M.
361 Capital first reported a position in Cigna in Q2 2017 and held it in 2 quarters.
361 Capital's Cigna position peaked at $4.11M in Q2 2017.
865 funds tracked by Wall St. Rank held Cigna as of Q4 2017.

Based on 361 Capital's 13F filing for Q4 2017, filed 14 Feb 2018.